Literature DB >> 9161838

Osteopenia following total gastrectomy in the rat--state of mineral metabolism and bone histomorphometry.

G Rümenapf1, P O Schwille, R G Erben, M Schreiber, W Fries, A Schmiedl, W Hohenberger.   

Abstract

Total gastrectomy (GX) in humans is frequently followed by osteopenia, but the details are unclear. The present investigations in the rat were aimed at elucidating its pathogenesis. Seventeen weeks after GX, we evaluated Ca, Mg and P metabolism as well as bone parameters, including fluorochrome-based bone histomorphometry. In GX rats, fecal Mg was increased, but intestinal absorption of P, Ca, and Mg was within normal limits, as was the urinary excretion of Ca, Mg, hydroxyproline and the pyridinium cross-links. In contrast, urinary P as well as cyclic AMP were significantly increased. In serum of GX rats, gastrin and 25-hydroxyvitamin D (25-OHD) were decreased, and Ca, Mg, P, parathyroid hormone (PTH), calcitonin, and the bone marker osteocalcin were normal, whereas 1,25-dihydroxyvitamin D [1,25(OH)2D] was significantly increased. GX rats had significantly reduced bone density and mineral content, severe high-turnover osteopenia, characterized by normal width but significantly decreased maturation time of osteoid, increased bone formation rate, and increased numbers of osteoclasts. We concluded that after GX (1) there is high-turnover osteopenia with normal mineralization and other histomorphometric features resembling those seen in states with hyperphosphaturia and subsequent hypervitaminosis D; (2) normal serum PTH levels and several indirect indicators of parathyroid gland function argue against the presence of (secondary) hyperparathyroidism, whereas increased bone mobilization due to elevated 1,25(OH)2D explains the maintenance of homeostasis of serum minerals, especially Ca, at the expense of bone mineral; (3) a complex interplay of mineral-metabolic effectors exists, among which low 25-OHD-PTH-independent renal phosphate losses, and high 1,25(OH)2D are prominent features. The presented animal model is recommended for future research in this area.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9161838     DOI: 10.1159/000129526

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  7 in total

1.  Postgastrectomy osteopenia in minipigs.

Authors:  G Rümenapf; P O Schwille
Journal:  Ann Surg       Date:  1999-04       Impact factor: 12.969

2.  Calcium gluconate supplementation is effective to balance calcium homeostasis in patients with gastrectomy.

Authors:  M Krause; J Keller; B Beil; I van Driel; J Zustin; F Barvencik; T Schinke; M Amling
Journal:  Osteoporos Int       Date:  2014-11-13       Impact factor: 4.507

3.  Ghrelin treatment reverses the reduction in weight gain and body fat in gastrectomised mice.

Authors:  C Dornonville de la Cour; A Lindqvist; E Egecioglu; Y C L Tung; V Surve; C Ohlsson; J-O Jansson; C Erlanson-Albertsson; S L Dickson; R Håkanson
Journal:  Gut       Date:  2005-04-21       Impact factor: 23.059

4.  Dietary 2-oxoglutarate mitigates gastrectomy-evoked structural changes in cartilage of female rats.

Authors:  Piotr Dobrowolski; Ewa Tomaszewska; Paulina Kurlak; Stefan G Pierzynowski
Journal:  Exp Biol Med (Maywood)       Date:  2015-07-22

Review 5.  Mineral metabolism and bone disease after bariatric surgery and ways to optimize bone health.

Authors:  Dave H Schweitzer
Journal:  Obes Surg       Date:  2007-11       Impact factor: 4.129

6.  Early phase metabolic bone disorders after gastrectomy: influence of active vitamin D treatment.

Authors:  Chiaki Ichikawa; Nobuhiro Takiguchi; Keiji Koda; Kenji Oda; Hirofumi Suzuki; Masaru Miyazaki
Journal:  Dig Dis Sci       Date:  2002-08       Impact factor: 3.199

7.  Influence of gastrectomy on cortical and cancellous bones in rats.

Authors:  Jun Iwamoto; Yoshihiro Sato; Hideo Matsumoto
Journal:  Gastroenterol Res Pract       Date:  2013-05-28       Impact factor: 2.260

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.